MiR-96-5p induced NDRG1 deficiency promotes prostate cancer migration and invasion through regulating the NF- κ B signaling pathway.

Autor: Lian, Zhenpeng^1,2 (AUTHOR), Chang, Taihao¹ (AUTHOR), Ma, Shenfei¹ (AUTHOR), Li, Jing² (AUTHOR), Zhang, Hongtuan¹ (AUTHOR), Wang, Xiaoming¹ (AUTHOR), Liu, Ranlu¹ (AUTHOR) liuranlu1976@126.com

Publikováno v: Cancer Biomarkers. 2022, Vol. 35 Issue 1, p83-98. 16p.

Impact of positive surgical margin location and perineural invasion on biochemical recurrence in patients undergoing radical prostatectomy.

Autor: Lian, Zhenpeng¹ (AUTHOR), Zhang, Hongtuan¹ (AUTHOR), He, Zhaowei¹ (AUTHOR), Ma, Shenfei¹ (AUTHOR), Wang, Xiaoming¹ (AUTHOR) doctorwxm2013@163.com, Liu, Ranlu¹ (AUTHOR) liuranlu1976@126.com

Publikováno v: World Journal of Surgical Oncology. 8/13/2020, Vol. 18 Issue 1, p1-8. 8p.

Loss of miR-516a-3p mediates upregulation of ABCC5 in prostate cancer and drives its progression.

Autor: Zhang, Hongtuan, Lian, Zhenpeng, Sun, Guangyu, Liu, Ranlu, Xu, Yong

Publikováno v: OncoTargets & Therapy. Jul2018, Vol. 11, p3853-3867. 15p.

Preliminary clinical practice of radical prostatectomy without preoperative biopsy.

Autor: Liu R; Department of Urology, Tianjin Medical University General Hospital, Tianjin 300052, China., Yin L; Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.; State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China., Ma S; Department of Urology & Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin 300211, China.; Department of Urology, Tianjin Union Medical Center, Tianjin 300121, China., Yang F; Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.; State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China., Lian Z; Department of Urology & Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin 300211, China.; Department of Urology, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, Henan 450003, China., Wang M; Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.; State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China., Lei Y; Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.; State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China., Dong X; Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.; State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China., Liu C; Department of Nuclear Medicine, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing 100142, China., Chen D; Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.; State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China., Han S; Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.; State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China., Xu Y; Department of Urology & Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin 300211, China., Xing N; Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.; State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.; Department of Urology, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, Shanxi 030013, China.

Publikováno v: Chinese medical journal [Chin Med J (Engl)] 2024 Aug 23. Date of Electronic Publication: 2024 Aug 23.